Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 2/20 | 0.36 |
| ▸ | CES1 | P23141 | 2/20 | 0.36 |
| ▸ | ACHE | P22303 | 1/20 | 0.33 |
| ▸ | BCHE | P06276 | 1/20 | 0.32 |
| ▸ | NFE2L2 | Q16236 | 3/20 | 0.32 |
| ▸ | ALB | P02768 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | ERN1 | O75460 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL38659149 | 0.75 | ALDH1A1 (0.43) | CES2CES1ACHEBCHENFE2L2 | |
| SCHEMBL4081893 | 0.75 | CES2 (0.39) | CES2CES1ACHEBCHENFE2L2 | |
| SCHEMBL1547829 | 0.71 | ACHE (0.39) | CES2CES1ACHEBCHENFE2L2 | |
| SCHEMBL10820270 | 0.71 | CES2 (0.36) | CES2CES1ACHEBCHENFE2L2 | |
| SCHEMBL362875 | 0.71 | CES2 (0.32) | CES2CES1ALDH1A1ERN1 | |
| SCHEMBL835486 | 0.71 | CES2 (0.42) | CES2CES1ACHEBCHEALB | |
| SCHEMBL21348480 | 0.70 | MGLL (0.31) | CES2CES1BCHE | |
| SCHEMBL14273550 | 0.69 | — | — | |
| SCHEMBL13769585 | 0.67 | ACHE (0.37) | CES2CES1ACHEALDH1A1 | |
| SCHEMBL162206 | 0.65 | GABRA1 (0.50) | CES2CES1BCHEALBALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2311112-B1 | ELECTRONIC DEVICES COMPRISING METAL COMPLEXES HAVING ISONITRILE LIGANDS | MERCK PATENT GMBH (DE) | 2012-03-14 | — | — | EP | disclosed |
| US-20110101327-A1 | Electronic Devices Comprising Metal Complexes Having Isonitrile Ligands | MERCK PATENT GMBH (DE) | 2011-05-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110101327-A1 | Electronic Devices Comprising Metal Complexes Having Isonitrile Ligands | EXOC4, ICMT, NCLN | CES2 2721/4885CES1 4833/4885ACHE 752/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.